Molecular imaging to support cancer immunotherapy

The advent of immune checkpoint inhibitors has reinvigorated the field of immuno-oncology. These monoclonal antibody-based therapies allow the immune system to recognize and eliminate malignant cells. This has resulted in improved survival of patients across several tumor types. However, not all pat...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Donk, Pim P, Oosting, Sjoukje F, Knapen, Daan G, van der Wekken, Anthonie J, Brouwers, Adrienne H, Lub-de Hooge, Marjolijn N, de Groot, Derk-Jan A, de Vries, Elisabeth GE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352987/
https://www.ncbi.nlm.nih.gov/pubmed/35922089
http://dx.doi.org/10.1136/jitc-2022-004949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352987/
https://www.ncbi.nlm.nih.gov/pubmed/35922089
http://dx.doi.org/10.1136/jitc-2022-004949

Ejemplares similares